28 Apr 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/04/28/3069207/28255/en/Evoke-Pharma-to-Present-New-Data-Comparing-Tardive-Dyskinesia-Incidence-in-Continuous-vs-Intermittent-Metoclopramide-Use-at-DDW-2025.html
03 Dec 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/12/03/2990651/28255/en/Evoke-Pharma-Receives-Notices-of-Allowance-for-Two-Additional-US-Patent-Applications-Protecting-GIMOTI.html
28 Oct 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/10/28/2969945/28255/en/Evoke-Pharma-EVERSANA-Announce-Statistically-Significant-Improvement-in-Patient-Outcomes-for-GLP-1-users-with-Diabetic-Gastroparesis-using-GIMOTI.html
22 Oct 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/10/22/2966954/28255/en/Evoke-Pharma-Announces-the-Appointment-of-Ben-Smeal-to-the-Board-of-Directors.html
19 Sep 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/09/19/2949365/28255/en/Evoke-Pharma-Reaffirms-Its-Commitment-to-Patients-with-Gastroparesis-Amid-Industry-Developments.html
16 Sep 2024
// BUSINESSWIRE